The Global Dasatinib Drugs Market was valued at US$ 1.3 billion in 2023 and is projected to reach US$ 1.8 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period (2023-2030).
Report Overview
Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).
This report provides a deep insight into the global Dasatinib Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Dasatinib Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Dasatinib Drugs market in any manner.
Global Dasatinib Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Bristol-Myers Squibb
- LUCIUS Pharma
Market Segmentation (by Type)
Market Segmentation (by Application)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Dasatinib Drugs Market
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Dasatinib Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Dasatinib Drugs
1.2 Key Market Segments
1.2.1 Dasatinib Drugs Segment by Type
1.2.2 Dasatinib Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Dasatinib Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Dasatinib Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Dasatinib Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Dasatinib Drugs Market Competitive Landscape
3.1 Global Dasatinib Drugs Sales by Manufacturers (2019-2024)
3.2 Global Dasatinib Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Dasatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Dasatinib Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Dasatinib Drugs Sales Sites, Area Served, Product Type
3.6 Dasatinib Drugs Market Competitive Situation and Trends
3.6.1 Dasatinib Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Dasatinib Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Dasatinib Drugs Industry Chain Analysis
4.1 Dasatinib Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Dasatinib Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Dasatinib Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Dasatinib Drugs Sales Market Share by Type (2019-2024)
6.3 Global Dasatinib Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Dasatinib Drugs Price by Type (2019-2024)
7 Dasatinib Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Dasatinib Drugs Market Sales by Application (2019-2024)
7.3 Global Dasatinib Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Dasatinib Drugs Sales Growth Rate by Application (2019-2024)
8 Dasatinib Drugs Market Segmentation by Region
8.1 Global Dasatinib Drugs Sales by Region
8.1.1 Global Dasatinib Drugs Sales by Region
8.1.2 Global Dasatinib Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Dasatinib Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Dasatinib Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Dasatinib Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Dasatinib Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Dasatinib Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Dasatinib Drugs Basic Information
9.1.2 Bristol-Myers Squibb Dasatinib Drugs Product Overview
9.1.3 Bristol-Myers Squibb Dasatinib Drugs Product Market Performance
9.1.4 Bristol-Myers Squibb Business Overview
9.1.5 Bristol-Myers Squibb Dasatinib Drugs SWOT Analysis
9.1.6 Bristol-Myers Squibb Recent Developments
9.2 LUCIUS Pharma
9.2.1 LUCIUS Pharma Dasatinib Drugs Basic Information
9.2.2 LUCIUS Pharma Dasatinib Drugs Product Overview
9.2.3 LUCIUS Pharma Dasatinib Drugs Product Market Performance
9.2.4 LUCIUS Pharma Business Overview
9.2.5 LUCIUS Pharma Dasatinib Drugs SWOT Analysis
9.2.6 LUCIUS Pharma Recent Developments
10 Dasatinib Drugs Market Forecast by Region
10.1 Global Dasatinib Drugs Market Size Forecast
10.2 Global Dasatinib Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Dasatinib Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Dasatinib Drugs Market Size Forecast by Region
10.2.4 South America Dasatinib Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Dasatinib Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Dasatinib Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Dasatinib Drugs by Type (2025-2030)
11.1.2 Global Dasatinib Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Dasatinib Drugs by Type (2025-2030)
11.2 Global Dasatinib Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Dasatinib Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Dasatinib Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Dasatinib Drugs Market Size Comparison by Region (M USD)
Table 5. Global Dasatinib Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Dasatinib Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Dasatinib Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Dasatinib Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dasatinib Drugs as of 2022)
Table 10. Global Market Dasatinib Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Dasatinib Drugs Sales Sites and Area Served
Table 12. Manufacturers Dasatinib Drugs Product Type
Table 13. Global Dasatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Dasatinib Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Dasatinib Drugs Market Challenges
Table 22. Global Dasatinib Drugs Sales by Type (Kilotons)
Table 23. Global Dasatinib Drugs Market Size by Type (M USD)
Table 24. Global Dasatinib Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Dasatinib Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Dasatinib Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Dasatinib Drugs Market Size Share by Type (2019-2024)
Table 28. Global Dasatinib Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Dasatinib Drugs Sales (Kilotons) by Application
Table 30. Global Dasatinib Drugs Market Size by Application
Table 31. Global Dasatinib Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Dasatinib Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Dasatinib Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Dasatinib Drugs Market Share by Application (2019-2024)
Table 35. Global Dasatinib Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Dasatinib Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Dasatinib Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Dasatinib Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Dasatinib Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Dasatinib Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Dasatinib Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Dasatinib Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Bristol-Myers Squibb Dasatinib Drugs Basic Information
Table 44. Bristol-Myers Squibb Dasatinib Drugs Product Overview
Table 45. Bristol-Myers Squibb Dasatinib Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bristol-Myers Squibb Business Overview
Table 47. Bristol-Myers Squibb Dasatinib Drugs SWOT Analysis
Table 48. Bristol-Myers Squibb Recent Developments
Table 49. LUCIUS Pharma Dasatinib Drugs Basic Information
Table 50. LUCIUS Pharma Dasatinib Drugs Product Overview
Table 51. LUCIUS Pharma Dasatinib Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. LUCIUS Pharma Business Overview
Table 53. LUCIUS Pharma Dasatinib Drugs SWOT Analysis
Table 54. LUCIUS Pharma Recent Developments
Table 55. Global Dasatinib Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Dasatinib Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Dasatinib Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Dasatinib Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Dasatinib Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Dasatinib Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Dasatinib Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Dasatinib Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Dasatinib Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Dasatinib Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Dasatinib Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Dasatinib Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Dasatinib Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Dasatinib Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Dasatinib Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Dasatinib Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Dasatinib Drugs Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Dasatinib Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Dasatinib Drugs Market Size (M USD), 2019-2030
Figure 5. Global Dasatinib Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Dasatinib Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Dasatinib Drugs Market Size by Country (M USD)
Figure 11. Dasatinib Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Dasatinib Drugs Revenue Share by Manufacturers in 2023
Figure 13. Dasatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Dasatinib Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Dasatinib Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Dasatinib Drugs Market Share by Type
Figure 18. Sales Market Share of Dasatinib Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Dasatinib Drugs by Type in 2023
Figure 20. Market Size Share of Dasatinib Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Dasatinib Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Dasatinib Drugs Market Share by Application
Figure 24. Global Dasatinib Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Dasatinib Drugs Sales Market Share by Application in 2023
Figure 26. Global Dasatinib Drugs Market Share by Application (2019-2024)
Figure 27. Global Dasatinib Drugs Market Share by Application in 2023
Figure 28. Global Dasatinib Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Dasatinib Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Dasatinib Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Dasatinib Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Dasatinib Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Dasatinib Drugs Sales Market Share by Country in 2023
Figure 37. Germany Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Dasatinib Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Dasatinib Drugs Sales Market Share by Region in 2023
Figure 44. China Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Dasatinib Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Dasatinib Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Dasatinib Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Dasatinib Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Dasatinib Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Dasatinib Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Dasatinib Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Dasatinib Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Dasatinib Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Dasatinib Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Dasatinib Drugs Market Share Forecast by Application (2025-2030)
